NCT02397122

Brief Summary

The aim of the trial is to evaluate the effectiveness of coronally advanced flap (CAF)+connective tissue graft(CTG)+platelet-rich fibrin(PRF) combination in Miller I and II recession treatment by comparing with CAF+CTG. 40 patients were surgically treated either with CAF+CTG+PRF (test group) or CAF+CTG (control group). Clinical parameters of plaque index (PI), gingival index (GI), vertical recession (VR), probing depth (PD), attachment level (AL), keratinized tissue width (KTW), horizontal recession (HR), MGJ localization (L-MGJ), tissue thickness (TT) were recorded at baseline, 3 months (PS1) and 6 months (PS2) post-surgery. Root coverage (RC), complete RC (CRC), attachment gain (AG), and keratinized tissue change (KTC) were also calculated.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

February 13, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 24, 2015

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

May 1, 2018

Completed
Last Updated

October 26, 2018

Status Verified

September 1, 2018

Enrollment Period

10 months

First QC Date

February 13, 2015

Results QC Date

April 1, 2017

Last Update Submit

September 26, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Vertical Recession

    Measured from cementoenamel junction to margin of the gingiva by periodontal probe

    Baseline, 6 weeks and 6 months

Secondary Outcomes (5)

  • Horizontal Recession

    Baseline, 6 weeks and 6 months

  • Probing Depth

    Baseline, 6 weeks and 6 months

  • Attachment Level

    Baseline, 6 weeks and 6 months

  • Keratinized Tissue Width

    Baseline, 6 weeks and 6 months

  • Tissue Thickness

    Baseline, 6 weeks and 6 months

Study Arms (2)

PRF+CAF+CTG

EXPERIMENTAL

platelet-rich fibrin + coronally advanced flap + connective tissue graft

Biological: platelet-rich fibrinProcedure: connective tissue graftProcedure: coronally advanced flap

CAF+CTG

ACTIVE COMPARATOR

coronally advanced flap + connective tissue graft

Procedure: connective tissue graftProcedure: coronally advanced flap

Interventions

autologous platelet-rich fibrin was isolated from venous blood of each patient by defined centrifugation methods

PRF+CAF+CTG

connective tissue graft was harvested from the palatal region of each patient by single incision method

CAF+CTGPRF+CAF+CTG

buccal gingival flap was raised by sharp-blunt-sharp dissection and positioned coronally to cover connective tissue graft (and platelet-rich fibrin gel)

CAF+CTGPRF+CAF+CTG

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Systemically healthy
  • Single Miller type I or II recession defect ≥ 3 mm localized to anterior/premolar area
  • No alveolar bone loss
  • Identifiable cemento-enamel junction
  • Probing depth ≤3mm

You may not qualify if:

  • Smoking
  • Pregnancy
  • History of periodontal surgery in last two years
  • Mobility
  • Excessive occlusal contacts
  • Caries
  • Loss of vitality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Gingival Recession

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Results Point of Contact

Title
Dr. H. Gencay Keceli
Organization
Kirikkale University

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DDS, PhD

Study Record Dates

First Submitted

February 13, 2015

First Posted

March 24, 2015

Study Start

February 1, 2013

Primary Completion

December 1, 2013

Study Completion

May 1, 2014

Last Updated

October 26, 2018

Results First Posted

May 1, 2018

Record last verified: 2018-09